Use of Activated Recombinant Human Factor VII in Cardiac Surgery

Clinical trial NCT00154427 · TERMINATED

Trial details

NCT number: NCT00154427
Sponsor: Novo Nordisk A/S
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Acquired Bleeding Disorder Cardiac Surgery Requiring Cardiopulmonary Bypass

Start date: 2004-08-01
Primary completion: 2007-11-01
Enrollment: 172

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.